Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Divalent metal transporter 1 (DMT1), also known as natural resistance-associated macrophage protein 2 (NRAMP2) or solute carrier family 11 member 2 (SLC11A2), is a transmembrane protein responsible for the uptake of various divalent metal ions—most notably ferrous iron (\(\mathrm{Fe}^{2+}\)), but also manganese (\(\mathrm{Mn}^{2+}\)), zinc (\(\mathrm{Zn}^{2+}\)), copper (\(\mathrm{Cu}^{2+}\)), cadmium (\(\mathrm{Cd}^{2+}\)), and calcium (\(\mathrm{Ca}^{2+}\)). It is highly conserved across species from bacteria to humans. In mammals, it plays a critical role in dietary iron absorption in the intestine by transporting reduced \(\mathrm{Fe}^{2+}\) into enterocytes. Its broad substrate specificity means that it can mediate uptake not only of essential metals but also potentially toxic ones. Dysregulation or mutation in this transporter is associated with diseases involving abnormal metal homeostasis such as anemia or overload syndromes[3][4][5].
H^+-coupled symport of divalent metal cations from the extracellular environment into cells
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Divalent metal transporter 1 (DMT1 (also known as NRAMP2 or DCT1)).